Luke Devey

Company: Quell Therapeutics

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Spearheading Acceleration of Next Generation Treg Therapies by Integrating Cell Based & Non Cell Based Approaches 4:00 pm

Highlighting the potential synergies and challenges with combining these two approaches and how this would positively impact future therapies Exploring successful examples of combination approaches to enhance current treatments Discussing regulatory considerations and approval pathways for combination therapies to address how this may impact therapeutic developmentRead more

day: Conference Day One